Related Experiment Video
Updated: Jun 9, 2026

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging
Published on: December 15, 2014
Exploring AI Approaches for Breast Cancer Detection and Diagnosis: A Review Article
Akbar Ali1, Mansoor Alghamdi2, Shahira Sofea Marzuki1
1Department of Chemical Pathology, School of Medical Science, Health Campus, Universiti Sains Malaysia 16150 Kubang Kerian, Kelantan, Malaysia.
Artificial intelligence (AI) enhances breast cancer diagnostics by improving lesion detection and reducing variability. Responsible integration requires addressing data quality, validation, and ethical considerations for safe clinical adoption.
Area of Science:
- Radiology and Pathology
- Medical Imaging
- Artificial Intelligence
Background:
- Deep learning, including convolutional neural networks (CNNs), Vision Transformers (ViTs), and generative adversarial networks (GANs), is transforming breast cancer diagnostics.
- AI integration into radiology and pathology workflows shows potential for enhanced lesion detection, triage, and reduced interpretive variability.
Purpose of the Study:
- To review recent advancements in AI for breast cancer diagnostics across various imaging modalities.
- To highlight the capabilities and challenges of AI in detection, classification, segmentation, and risk prediction.
- To discuss barriers to clinical adoption and propose priorities for responsible AI integration.
Main Methods:
- Synthesis of recent literature on AI applications in mammography, digital breast tomosynthesis (DBT), ultrasound, MRI, and whole-slide imaging.
- Focus on deep learning models like CNNs, ViTs, and GANs for diagnostic tasks.
- Analysis of factors influencing AI performance, generalizability, and clinical adoption.
Main Results:
- AI systems can improve lesion detection and reduce variability when integrated into clinical workflows.
- Performance and generalizability are contingent on dataset quality, heterogeneity, and model calibration, with risks of diminished performance and miscalibration on external data.
- AI models are increasingly used for segmentation and risk prediction, integrating imaging with clinicopathological and genomic data for personalized patient management.
- Generative adversarial networks (GANs) can aid in data augmentation but require careful quality control and bias monitoring.
- Key barriers to adoption include validation issues, domain shifts, reporting variability, interpretability, and regulatory concerns.
Conclusions:
- AI holds significant promise to augment, not replace, clinicians in breast cancer diagnostics.
- Priorities for responsible AI integration include multi-site validation, transparent reporting, bias mitigation, robust calibration, and continuous monitoring for safety and equity.
More Related Videos
06:03Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
03:07Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025